These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 11784369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U, Kaldonska M, Klodowska-Duda G, Wyska E, Safranow K, Bialecka M, Gawronska-Szklarz B.
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Force overflow and levodopa-induced dyskinesias in Parkinson's disease.
    Wenzelburger R, Zhang BR, Pohle S, Klebe S, Lorenz D, Herzog J, Wilms H, Deuschl G, Krack P.
    Brain; 2002 Apr; 125(Pt 4):871-9. PubMed ID: 11912119
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of motor fluctuations in Parkinson's disease.
    Widnell K.
    Mov Disord; 2005 Apr; 20 Suppl 11():S17-22. PubMed ID: 15822108
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Levodopa induced motor complications in Thai Parkinson's disease patients.
    Kulkantrakorn K, Tiamkao S, Pongchaiyakul C, Pulkes T.
    J Med Assoc Thai; 2006 May; 89(5):632-7. PubMed ID: 16756048
    [Abstract] [Full Text] [Related]

  • 14. Motor complications in an incident Parkinson's disease cohort.
    Scott NW, Macleod AD, Counsell CE.
    Eur J Neurol; 2016 Feb; 23(2):304-12. PubMed ID: 26074125
    [Abstract] [Full Text] [Related]

  • 15. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
    Goetz CG, Stebbins GT, Blasucci LM.
    Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
    [Abstract] [Full Text] [Related]

  • 16. [Fluctuations and dyskinesias as early L-dopa-induced motor complications in severe Parkinsonian's patients].
    Vaamonde J, Ibáñez R, Gudín M, Hernández A.
    Neurologia; 2003 Apr; 18(3):162-5. PubMed ID: 12677484
    [Abstract] [Full Text] [Related]

  • 17. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F, Battaglia A, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, PKDS009 Study Group.
    CNS Drugs; 2004 Apr; 18(11):733-46. PubMed ID: 15330687
    [Abstract] [Full Text] [Related]

  • 18. Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.
    Nicoletti A, Mostile G, Nicoletti G, Arabia G, Iliceto G, Lamberti P, Marconi R, Morgante L, Barone P, Quattrone A, Zappia M.
    J Neurol; 2016 May; 263(5):888-894. PubMed ID: 26964541
    [Abstract] [Full Text] [Related]

  • 19. Risk of Disabling Response Fluctuations and Dyskinesias for Dopamine Agonists Versus Levodopa in Parkinson's Disease.
    Haaxma CA, Horstink MW, Zijlmans JC, Lemmens WA, Bloem BR, Borm GF.
    J Parkinsons Dis; 2015 May; 5(4):847-53. PubMed ID: 26444087
    [Abstract] [Full Text] [Related]

  • 20. Factors associated with motor complications in Parkinson's disease.
    Kadastik-Eerme L, Taba N, Asser T, Taba P.
    Brain Behav; 2017 Oct; 7(10):e00837. PubMed ID: 29075578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.